CYTOCARE REPORTS FIRST QUARTER RESULTS
CYTOCARE REPORTS FIRST QUARTER RESULTS IRVINE, Calif., April 24 /PRNewswire/ -- Cytocare Inc.
(NASDAQ: CYTI) announced today earnings for the period ended March 31, 1992 of $388,596 or $.08 per share on revenues of $3,286,702. This compares with first quarter 1991 earnings of $501,534 or $.10 per share on revenues of $2,506,700. Results for the respective first quarters of 1992 and 1991 include procedure fees, equipment sales, maintenance fees, interest income and the realization of deferred revenue. Cytocare's research projects in urologic pharmaceuticals and devices are accelerating and an increasing portion of earnings will be plowed back into developing these markets this year.
CYTOCARE INC. Condensed Comparative Operating Results March 31, 1992 For the three months ended March 31, 1992 1991 Revenues $3,286,702(a) $2,506,700(b) Income before taxes $456,596(a) $536,534(b) Net income $388,596 $501,534 Primary earnings per share: Net income $.08 $.10 Fully diluted earnings per share: Net income $.08 $.10 Number of shares used in the computation of earnings per share: Primary 5,141,439 4,837,727 Fully diluted 5,141,439 4,943,028 (a) Includes interest income of $171,018 and the recognition of $287,000 of deferred revenue. (b) Includes interest income of $179,747 and the recognition of $219,600 of deferred revenue. -0- 4/24/92 /CONTACT: Jeannine Cormane of Cytocare, 714-587-0500/ (CYTI) CO: Cytocare Inc. ST: California IN: MTC SU: ERN
EH-JL -- LA009 -- 2301 04/24/92 09:04 EDT
|Printer friendly Cite/link Email Feedback|
|Date:||Apr 24, 1992|
|Previous Article:||ASTROTECH INTERNATIONAL CORPORATION DECLARES THIRD QUARTER DIVIDEND ON ITS $1.20 CUMULATIVE CONVERTIBLE PREFERRED DIVIDEND|
|Next Article:||ALFRED BERKELEY JOINS COMSHARE'S BOARD OF DIRECTORS|